Geguiera, Erlinda N.

HRN: 22-74-77  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2023
MUPIROCIN 2%, 15G (TUBE)
03/14/2023
03/20/2023
TOPICAL
15g
Bid
Pressure Ulcer
Waiting Final Action 
03/16/2023
CEFTRIAXONE 1G (VIAL)
03/16/2023
03/22/2023
IV
1g
Q12
Fracture Closed Subtrochanteric Femur Right
Waiting Final Action 
03/16/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/16/2023
03/22/2023
IV
600mg
Q6
Fracture Closed Subtrochanteric Femur Right
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: